47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | 17,6 | |||
Gross profit (loss) | -20,3 | -40,7 | -64,9 | -59,2 |
EBITDA | 33,6 | |||
Short time liabilities | 5,6 | |||
Income tax | -0,4 | 1,5 | -1,6 | -206,8 |
Other operating costs | -95,9 | |||
Equity capital | -525 | -567,2 | -630,5 | -11,2 |
Operating profit (EBIT) | 33,6 | |||
Assets | 1,8 | 0 | 0 | 0 |
Net profit (loss) | -19,9 | -42,2 | -63,3 | -49,9 |
Cash | 0 | |||
Net income from sale | -100 | |||
Liabilities and provisions for liabilities | 526,8 | 567,2 | 630,5 | 11,2 |
Working assets | 0 | 0 | 0 | 0 |
Other income costs | -99,1 | |||
Basic operational activity income | 0 | 0 | 0 | 0 |
Depreciation | 0 | |||
% | % | % | p.p. | |
Profitability of capital | -1,5 | |||
Equity capital to total assets | -29 377,9 | -25 257,5 | ||
Gross profit margin | ||||
EBITDA Margin | ||||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 416 448 | |||
Current financial liquidity indicator | 0 | |||
Net dept to EBITDA | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane